Glenmark
Pharmaceutical's Crofelemer enters phase-3 clinical
trials 5:15 AM 12/22/2008
Economic
Times,India
Glenmark Pharmaceuticals said its Crofelemer for multiple indications including HIV-associated
diarrhea has entered phase-3 clinical trials.
...
Alizyme up on Takeda drug
update 4:12 AM 12/22/2008
Forbes -
NY,USA
Alizyme shares rise after partner Takeda announces the start of large-scale trials with its obesity
drug Cetilistat. Alizyme could receive up to $32 million in development and sales milestones.
...
FDA
approves new version of Emergent vaccine 6:21 PM 12/19/2008
MSNBC - USA
Emergent BioSolutions Inc said the US FDA approved a new version of its anthrax
vaccine Biothrax that requires fewer injections.
...
EU
clears Israel's Teva to buy Barr Pharmaceutical 2:44 PM 12/19/2008
Reuters - USA
The European Commission approved Teva Pharmaceutical's planned
takeover of US biopharmaceutical and generic drug maker Barr.
...
US
flu shows resistance to flu drug, CDC says 2:34 PM 12/19/2008
Reuters - USA
A common strain of influenza in the US is resistant to the most
popular drug used to treat it. Tamiflu is used in a minority of cases.
...
FDA
holds off decision on J&J psoriasis drug 11:00 AM 12/19/2008
Reuters - USA
The US FDA will not require new studies on Johnson & Johnson's
promising psoriasis drug ustekinumab, but delayed approval until they receive risk-mitigation information.
...
AstraZeneca,
MAP Pharma to develop asthma drug 9:57 AM 12/19/2008
Reuters - USA
AstraZeneca Plc signed an agreement to develop and market MAP Pharmaceuticals'
pediatric asthma drug unit dose budesonide (UDB) as a potential treatment for pediatric asthma in children aged
12 months to 8 years.
...
European
committee recommends Lilly drug approval 3:27 PM 12/18/2008
Forbes - NY,USA
Eli Lilly's blood thinner prasugrel has moved closer to market
with an approval recommendation from a European Medicines Agency committee. ...
Pfizer
to buy rights to experimental biotech drug from
Auxilium 2:27 PM 12/18/2008
SmartBrief -
Washington,DC,USA
Pfizer purchased development and marketing rights to Auxilium Pharmaceuticals'
Xiaflex. It treats two conditions caused by collagen accumulation; Dupuytren's contracture and Peyronie's
disease (decreased flexibility and pain in the penis).
...
Adolor
to stop development of bowel dysfunction drug 1:21 PM 12/18/2008
Reuters - USA
Adolor Corp will stop developing its experimental treatment Entereg
(alvimopan) for chronic bowel dysfunction in patients on opioid therapy.
...
<- Day Earlier | Today's News
